此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Intravenous Versus Intra-articular Tranexamic Acid for Visual Clarity During Arthroscopic Rotator Cuff Repair

2026年9月30日 更新者:Konkuk University Medical Center

The Effect of Intravenous Versus Intra-articular Tranexamic Acid on Visual Clarity During Arthroscopic Rotator Cuff Repair: A Prospective, Randomized, Double-blind Controlled Trial

This single-center, prospective, randomized, double-blind controlled trial evaluated whether intravenous (IV) or intra-articular (IA) administration of tranexamic acid (TXA) improves intraoperative visual clarity, compared with a no-TXA control, during arthroscopic rotator cuff repair. Patients with rotator cuff tears were randomly allocated to one of three groups: a control group receiving no TXA; an IA group in which 500 mg of TXA was added to each 1 L of normal-saline irrigation fluid; and an IV group receiving 1000 mg of TXA intravenously 10 minutes before surgery. The operating surgeon graded visual clarity on a 0-10 numeric scale at the end of each of six predefined surgical stages. Secondary outcomes included total operative time, estimated blood loss, irrigation-fluid volume, the number of irrigation-pressure increases, postoperative shoulder swelling, and postoperative day 1 pain.

研究概览

地位

完全的

条件

干预/治疗

研究类型

介入性

注册 (实际的)

115

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Seoul
      • Seoul、Seoul、韩国、05030
        • Konkuk University Medical Center

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 80年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Age 18-80 years
  • Diagnosed with a rotator cuff tear
  • Failure of conservative treatment for more than 3 months
  • Rotator cuff deemed repairable on magnetic resonance imaging

Exclusion Criteria:

  • Known hypersensitivity to tranexamic acid
  • Previous cerebrovascular accident
  • Coronary stent or other history of thromboembolic disease
  • Anticoagulant therapy
  • Uncontrolled hypertension (systolic pressure > 180 mmHg)
  • Abnormal prothrombin time or activated partial thromboplastin time
  • Acute traumatic rotator cuff tear
  • Irreparable rotator cuff tear

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:双倍的

武器和干预

参与者组/臂
干预/治疗
无干预:Control

No tranexamic acid; arthroscopic rotator cuff repair performed with plain normal-saline irrigation.

实验性的:Intra-articular TXA

Tranexamic acid 500 mg added to each 1 L of normal-saline irrigation fluid during arthroscopic rotator cuff repair.

500 mg of tranexamic acid added per 1 L of normal-saline irrigation fluid.

实验性的:Intravenous TXA

Tranexamic acid 1000 mg administered intravenously 10 minutes before surgery; plain normal-saline irrigation as in the control group.

1000 mg of tranexamic acid administered intravenously 10 minutes before surgery.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Intraoperative visual clarity
大体时间:Intraoperatively, at the end of each of the six surgical stages

Surgeon-rated clarity of the arthroscopic surgical field on a 0-10 numeric scale (0 = poorest visualization, 10 = optimal visualization), scored at the end of each of six surgical stages: glenohumeral procedure, subacromial bursectomy, acromioplasty, rotator cuff inspection, medial-row repair, and lateral-row repair.

Intraoperatively, at the end of each of the six surgical stages

次要结果测量

结果测量
措施说明
大体时间
Total operative time
大体时间:Intraoperative (duration of surgery)

Total duration of the surgical procedure.

Intraoperative (duration of surgery)
Estimated blood loss
大体时间:postoperative day 1

Estimated blood loss calculated from serum hemoglobin measured before and after surgery using the formula described by Good et al.

postoperative day 1
Irrigation-fluid volume
大体时间:Intraoperatively, from skin incision to skin closure (duration of surgery)

Total volume of irrigation fluid used during the procedure.

Intraoperatively, from skin incision to skin closure (duration of surgery)
Number of irrigation-pressure increases
大体时间:Intraoperatively, from skin incision to skin closure (duration of surgery)

Number of times the irrigation pump pressure was increased to control bleeding affecting the surgical field

Intraoperatively, from skin incision to skin closure (duration of surgery)
Postoperative shoulder swelling
大体时间:Baseline (pre-operative) and postoperative day 1

Shoulder circumference and diameter measured at the axillary and deltoid sites with the arm abducted ~30 degrees, compared between pre-operative and postoperative day 1

Baseline (pre-operative) and postoperative day 1
Postoperative pain
大体时间:Pain assessed using the Visual Analog Scale (VAS) for pain, ranging from 0 (no pain) to 10 (worst imaginable pain); higher scores indicate worse outcome, on postoperative day 1

Pain assessed using a visual analog scale (VAS) on postoperative day 1

Pain assessed using the Visual Analog Scale (VAS) for pain, ranging from 0 (no pain) to 10 (worst imaginable pain); higher scores indicate worse outcome, on postoperative day 1

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

调查人员

  • 首席研究员:Seok Won Chung, MD、Konkuk University Medical Center

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2023年5月18日

初级完成 (实际的)

2024年8月25日

研究完成 (实际的)

2024年8月26日

研究注册日期

首次提交

2026年6月17日

首先提交符合 QC 标准的

2026年6月29日

首次发布 (实际的)

2026年7月7日

研究记录更新

最后更新发布 (实际的)

2026年10月5日

上次提交的符合 QC 标准的更新

2026年9月30日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

其他研究编号

  • 2022-12-017

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

There is no plan to share individual participant data.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.